The company has issued commercial papers of Rs 100 crore on April 18, 2017. The tenure of instrument is 63 days, Jubilant Life Sciences said in a BSE filing.
The company however did not specify what it planned to do with the money raised.
"The coupon/interest offered is 6.49 per cent per annum," it added.
Commercial paper (CP) is an unsecured money market instrument issued in the form of a promissory note.
It was introduced in 1990 in India with a view to enable highly rated corporate borrowers to diversify their sources of short-term borrowings and to provide an additional instrument to investors.
Disclaimer: No Business Standard Journalist was involved in creation of this content